Efficacy of Siponimod in Managing Relapsing-Remitting Multiple Sclerosis: Insights from a Real-World Cohort Study in a Chinese Center - Quiz - MDSpire

Efficacy of Siponimod in Managing Relapsing-Remitting Multiple Sclerosis: Insights from a Real-World Cohort Study in a Chinese Center

  • By

  • Hongmei Tan

  • Lei Zhou

  • Yue Gao

  • Chongbo Zhao

  • Chuanzhen Lu

  • Qiang Dong

  • Jingzi ZhangBao

  • Chao Quan

  • February 18, 2026

  • 0 min

Share

Original Source(s)

Efficacy of Siponimod in Managing Relapsing-Remitting Multiple Sclerosis: Insights from a Real-World Cohort Study in a Chinese Center

  • by Hongmei Tan, Lei Zhou, Yue Gao, Chongbo Zhao, Chuanzhen Lu, Qiang Dong, Jingzi ZhangBao, Chao Quan

  • February 18, 2026

Related Content

An Oxidative Glial Profile as a Predictor of Disability and Cognitive Decline in Primary Progressive Multiple Sclerosis

Digging deeper into NINJ1: its multifaceted role in central nervous system diseases

Associations of Serum Alpha-Linolenic Acid with Disability and Brain Volume in Multiple Sclerosis: A Concise Replication Study